Fig. 3. The cervical organoids show differential drug responses. (A) The representative dose-response curves for carboplatin, Ly290042, cisplatin, paclitaxel, and rapamycin in PDOs. (B) The CC50 values for anticancer drugs in CC organoids. Data are expressed as the mean ± standard deviation.
CC, cervical cancer; CC50, half-maximal cytotoxic concentration; NA, not applicable; PDO, patient-derived organoid.